Displaying 1 - 12 of 23

Display:

12 24 48

Viral Hepatitis

5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View

Viral Hepatitis

5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View

Viral Hepatitis

5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View

Viral Hepatitis

5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View

Metabolism, Alcohol & Toxicity

3

Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021

View

Metabolism, Alcohol & Toxicity

3

Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021

View

Metabolism, Alcohol & Toxicity

3

Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021

View

Viral Hepatitis

6

Gilead Sciences: A new beginning in hepatitis delta - ILC 2021

View

Viral Hepatitis

6

Gilead Sciences: A new beginning in hepatitis delta - ILC 2021

View

Viral Hepatitis

6

Gilead Sciences: A new beginning in hepatitis delta - ILC 2021

View

Viral Hepatitis

6

Gilead Sciences: A new beginning in hepatitis delta - ILC 2021

View

Viral Hepatitis

6

Gilead Sciences: A new beginning in hepatitis delta - ILC 2021

View

Displaying 1 - 12 of 23

Display:

12 24 48